Schedule 13G ownership disclosure

Arbutus Biopharma Corp

Common Shares, without par value · CUSIP: 03879J100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Two Seas Capital LP

    Shares: 12,589,158 · Class: 6.5%

  • Two Seas Capital GP LLC

    Shares: 12,589,158 · Class: 6.5%

  • Sina Toussi

    Shares: 12,589,158 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-26-000149
Form type
SCHEDULE 13G/A
Filer
Arbutus Biopharma Corp
CIK
CIK 1447028
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub